Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06997458 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

Study acronym: LOLA-PROJECT
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 30, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The objective of the LOLA Project is to analyse the impact of adopting xF liquid biopsy panel, in the real world of the Andalusian Health Public System in terms of impact on clinical practice and cost through the assessment of clinical impact, duration of turnaround time (TAT) of xF test vs standard of care and the analysis of resource utilisation.
Trial Details
NCT Number NCT06997458
Lead Sponsor Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Collaborators: Tempus AI
Conditions
(from sponsor)		 Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Related terms Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov